BlackRock’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $192M | Sell |
21,425,849
-1,343,397
| -6% | -$12M | ﹤0.01% | 1626 |
|
2025
Q1 | $171M | Buy |
22,769,246
+674,083
| +3% | +$5.06M | ﹤0.01% | 1675 |
|
2024
Q4 | $166M | Buy |
22,095,163
+1,179,192
| +6% | +$8.87M | ﹤0.01% | 1757 |
|
2024
Q3 | $159M | Buy |
20,915,971
+959,716
| +5% | +$7.29M | ﹤0.01% | 1780 |
|
2024
Q2 | $123M | Buy |
19,956,255
+1,515,526
| +8% | +$9.37M | ﹤0.01% | 1894 |
|
2024
Q1 | $93.7M | Sell |
18,440,729
-240,641
| -1% | -$1.22M | ﹤0.01% | 2062 |
|
2023
Q4 | $112M | Buy |
18,681,370
+1,907,066
| +11% | +$11.4M | ﹤0.01% | 1978 |
|
2023
Q3 | $119M | Buy |
16,774,304
+1,278,601
| +8% | +$9.05M | ﹤0.01% | 1876 |
|
2023
Q2 | $109M | Buy |
15,495,703
+670,905
| +5% | +$4.72M | ﹤0.01% | 1970 |
|
2023
Q1 | $124M | Sell |
14,824,798
-94,157
| -0.6% | -$785K | ﹤0.01% | 1856 |
|
2022
Q4 | $171M | Buy |
14,918,955
+1,143,960
| +8% | +$13.1M | 0.01% | 1644 |
|
2022
Q3 | $174M | Sell |
13,774,995
-212,423
| -2% | -$2.68M | 0.01% | 1571 |
|
2022
Q2 | $148M | Sell |
13,987,418
-114,557
| -0.8% | -$1.21M | ﹤0.01% | 1737 |
|
2022
Q1 | $229M | Sell |
14,101,975
-685,420
| -5% | -$11.1M | 0.01% | 1569 |
|
2021
Q4 | $205M | Sell |
14,787,395
-543,463
| -4% | -$7.53M | 0.01% | 1714 |
|
2021
Q3 | $220M | Sell |
15,330,858
-150,469
| -1% | -$2.16M | 0.01% | 1629 |
|
2021
Q2 | $245M | Sell |
15,481,327
-760,448
| -5% | -$12M | 0.01% | 1613 |
|
2021
Q1 | $165M | Sell |
16,241,775
-17,970
| -0.1% | -$183K | ﹤0.01% | 1842 |
|
2020
Q4 | $121M | Buy |
16,259,745
+315,852
| +2% | +$2.35M | ﹤0.01% | 1940 |
|
2020
Q3 | $54.8M | Buy |
15,943,893
+1,276,979
| +9% | +$4.39M | ﹤0.01% | 2196 |
|
2020
Q2 | $69.9M | Buy |
14,666,914
+1,271,297
| +9% | +$6.06M | ﹤0.01% | 2049 |
|
2020
Q1 | $26.8M | Buy |
13,395,617
+1,245,406
| +10% | +$2.49M | ﹤0.01% | 2419 |
|
2019
Q4 | $41.9M | Buy |
12,150,211
+2,555,431
| +27% | +$8.82M | ﹤0.01% | 2450 |
|
2019
Q3 | $27.5M | Buy |
9,594,780
+668,889
| +7% | +$1.92M | ﹤0.01% | 2610 |
|
2019
Q2 | $33.8M | Buy |
8,925,891
+228,525
| +3% | +$866K | ﹤0.01% | 2528 |
|
2019
Q1 | $70.8M | Sell |
8,697,366
-152,061
| -2% | -$1.24M | ﹤0.01% | 2076 |
|
2018
Q4 | $71.4M | Buy |
8,849,427
+79,571
| +0.9% | +$642K | ﹤0.01% | 2018 |
|
2018
Q3 | $66.9M | Buy |
8,769,856
+1,013,905
| +13% | +$7.74M | ﹤0.01% | 2208 |
|
2018
Q2 | $44.4M | Buy |
7,755,951
+281,532
| +4% | +$1.61M | ﹤0.01% | 2415 |
|
2018
Q1 | $35.7M | Sell |
7,474,419
-139,861
| -2% | -$667K | ﹤0.01% | 2454 |
|
2017
Q4 | $37.4M | Buy |
7,614,280
+993,100
| +15% | +$4.88M | ﹤0.01% | 2436 |
|
2017
Q3 | $34.7M | Buy |
6,621,180
+362,803
| +6% | +$1.9M | ﹤0.01% | 2473 |
|
2017
Q2 | $34.8M | Buy |
6,258,377
+244,100
| +4% | +$1.36M | ﹤0.01% | 2443 |
|
2017
Q1 | $50.5M | Buy |
6,014,277
+6,004,070
| +58,823% | +$50.4M | ﹤0.01% | 2202 |
|
2016
Q4 | $65K | Buy |
10,207
+231
| +2% | +$1.47K | ﹤0.01% | 2740 |
|
2016
Q3 | $44K | Sell |
9,976
-6,699
| -40% | -$29.5K | ﹤0.01% | 2961 |
|
2016
Q2 | $48K | Buy |
16,675
+11,883
| +248% | +$34.2K | ﹤0.01% | 2909 |
|
2016
Q1 | $14K | Buy |
4,792
+2,769
| +137% | +$8.09K | ﹤0.01% | 2953 |
|
2015
Q4 | $21K | Buy |
2,023
+551
| +37% | +$5.72K | ﹤0.01% | 2506 |
|
2015
Q3 | $17K | Sell |
1,472
-58,800
| -98% | -$679K | ﹤0.01% | 2445 |
|
2015
Q2 | $900K | Sell |
60,272
-3,345
| -5% | -$49.9K | ﹤0.01% | 1377 |
|
2015
Q1 | $575K | Hold |
63,617
| – | – | ﹤0.01% | 1477 |
|
2014
Q4 | $774K | Hold |
63,617
| – | – | ﹤0.01% | 1241 |
|
2014
Q3 | $622K | Sell |
63,617
-4,300
| -6% | -$42K | ﹤0.01% | 1278 |
|
2014
Q2 | $866K | Buy |
67,917
+67,903
| +485,021% | +$866K | ﹤0.01% | 1209 |
|
2014
Q1 | $0 | Buy |
+14
| New | – | ﹤0.01% | 3100 |
|